Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 4:30 PM View:  | Black Diamond Therapeutics,... (BDTX) | 20-Sep-24 | Grant | 3,007 | $4.78 | $14,373.50 | < 1% 4.5M to 4.51M | (6%) |
| 17-Sep-24 8:24 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Conversion Duplicate | 3,114,490 | -- | -- | 100% 0 to 3.11M | |
| 17-Sep-24 8:24 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Private Purchase Duplicate | 500,000 | $16.00 | $8,000,000.00 | 16% 3.11M to 3.61M | |
| 21-Jun-24 4:25 PM View: | Black Diamond Therapeutics,... (BDTX) | 21-Jun-24 | Grant | 2,887 | $4.98 | $14,377.30 | < 1% 4.5M to 4.5M | (10%) |
| 24-Apr-24 5:00 PM View: | Korro Bio, Inc. (KRRO) | 22-Apr-24 | Grant Duplicate | 17,857 | $56.00 | $999,992.00 | 2% 1.07M to 1.09M | |
| 03-Apr-24 9:00 PM View: | Black Diamond Therapeutics,... (BDTX) | 15-Mar-24 | Grant | 3,166 | $4.54 | $14,373.60 | < 1% 4.5M to 4.5M | (< 1%) |
| 15-Dec-23 4:48 PM View: | Black Diamond Therapeutics,... (BDTX) | 15-Dec-23 | Grant | 4,455 | $2.73 | $12,162.20 | < 1% 4.49M to 4.5M | |
| 18-Dec-23 4:40 PM View: | Cvrx, Inc. (CVRX) | 14-Dec-23 | Option Exercise | 316 | $0.24 | $74.89 | 100% 0 to 0.32K | |
| 07-Nov-23 9:15 PM View: | Korro Bio, Inc. (KRRO) | 03-Nov-23 | Grant | 1,072,940 | -- | -- | 100% 0 to 1.07M | |
| 18-Sep-23 5:34 PM View: | Black Diamond Therapeutics,... (BDTX) | 15-Sep-23 | Grant | 3,299 | $3.60 | $11,876.40 | < 1% 4.49M to 4.49M | |
| 19-Jul-23 7:06 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 17-Jul-23 | Purchase Duplicate | 333,333 | $3.00 | $999,999.00 | 1% 24.14M to 24.47M | |
| 06-Jul-23 4:45 PM View: | Black Diamond Therapeutics,... (BDTX) | 05-Jul-23 | Market Purchase | 1,000,000 | $5.00 | $5,000,000.00 | 29% 3.49M to 4.49M | (10%) |
| 15-Jun-23 4:28 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Acquisition (other) | 30,135 | -- | -- | < 1% 4.19M to 4.22M | |
| 15-Jun-23 4:28 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 13-Jun-23 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (48%) 4.22M to 2.19M | |
| 05-Jun-23 4:46 PM View: | Arcellx, Inc. (ACLX) | 01-Jun-23 | Acquisition (other) | 113 | -- | -- | 40% 0.28K to 0.4K | |
| 05-Jun-23 4:46 PM View: | Arcellx, Inc. (ACLX) | 01-Jun-23 | Acquisition (other) | 28 | -- | -- | 7% 0.4K to 0.42K | |
| 20-Mar-23 4:41 PM View: | Black Diamond Therapeutics,... (BDTX) | 16-Mar-23 | Grant | 7,111 | $1.67 | $11,875.40 | < 1% 3.48M to 3.48M | |
| 04-Jan-23 5:16 PM View: | Oyster Point Pharma, Inc. (OYST) | 03-Jan-23 | Disposition | 13,639 | -- | -- | (100%) 13.64K to 0 | |
| 22-Dec-22 6:31 PM View: | Arcellx, Inc. (ACLX) | 20-Dec-22 | Acquisition (other) | 57 | -- | -- | 100% 0 to 57 | |
| 22-Dec-22 6:31 PM View: | Arcellx, Inc. (ACLX) | 20-Dec-22 | Acquisition (other) | 226 | -- | -- | 396% 57 to 0.28K | |
| 19-Dec-22 9:27 PM View: | Black Diamond Therapeutics,... (BDTX) | 16-Dec-22 | Grant | 7,917 | $1.50 | $11,875.50 | < 1% 3.47M to 3.48M | |
| 02-Dec-22 5:03 PM View: | Akouos, Inc. (AKUS) | 30-Nov-22 | Disposition (change in control) Duplicate | 4,294,210 | -- | -- | (100%) 4.29M to 0 | |
| 19-Sep-22 6:39 PM View: | Black Diamond Therapeutics,... (BDTX) | 16-Sep-22 | Grant | 4,532 | $2.62 | $11,873.80 | < 1% 3.46M to 3.47M | |
| 17-Jun-22 4:35 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Jun-22 | Grant | 5,850 | $2.03 | $11,875.50 | < 1% 3.46M to 3.46M | |
| 14-Jun-22 4:08 PM View: | Minerva Surgical Inc (UTRS) | 10-Jun-22 | Grant | 49,792 | $2.41 | $119,999.00 | 587% 8.49K to 58.28K | |
| 08-Jun-22 4:49 PM View: | Oyster Point Pharma, Inc. (OYST) | 06-Jun-22 | Grant | 3,573 | -- | -- | 35% 10.07K to 13.64K | |
| 26-May-22 6:19 PM View: | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:19 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 13-Apr-22 5:10 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-22 | Purchase | 3,580,530 | $1.90 | $6,803,000.00 | 46% 7.79M to 11.37M | |
| 18-Mar-22 4:15 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Mar-22 | Grant | 4,346 | $3.02 | $13,124.90 | < 1% 3.45M to 3.46M | |
| 27-Dec-21 4:41 PM View: | Metacrine, Inc. (MTCR) | 22-Dec-21 | Market Sale Duplicate | 459,700 | $0.97 | $444,853.00 | (15%) 3.02M to 2.56M | 14% |
| 17-Dec-21 4:50 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Dec-21 | Grant | 2,472 | $5.31 | $13,126.30 | < 1% 3.45M to 3.45M | (2%) |
| 27-Dec-21 4:41 PM View: | Metacrine, Inc. (MTCR) | 10-Dec-21 | Market Sale Duplicate | 37,570 | $1.32 | $49,630.00 | (1%) 3.06M to 3.02M | 37% |
| 28-Oct-21 9:06 PM View: | Minerva Surgical Inc (UTRS) | 26-Oct-21 | Conversion | 8,487 | -- | -- | 100% 0 to 8.49K | |
| 19-Oct-21 9:11 PM View: | Trevi Therapeutics, Inc. (TRVI) | 18-Oct-21 | Purchase Duplicate | 1,851,850 | -- | -- | 31% 5.94M to 7.79M | |
| 23-Sep-21 10:00 PM View: | Black Diamond Therapeutics,... (BDTX) | 17-Sep-21 | Grant | 1,326 | $9.90 | $13,127.40 | < 1% 3.45M to 3.45M | (6%) |
| 30-Jun-21 6:01 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:01 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 10:00 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Conversion Duplicate | 69,963,800 | -- | -- | 100% 0 to 69.96M | |
| 30-Jun-21 10:00 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Market Purchase Duplicate | 1,944,440 | $18.00 | $35,000,000.00 | 3% 69.96M to 71.91M | |
| 22-Jun-21 7:18 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Jun-21 | Grant | 1,014 | $12.95 | $13,131.30 | < 1% 3.45M to 3.45M | (4%) |
| 09-Jun-21 8:52 PM View: | Oyster Point Pharma, Inc. (OYST) | 07-Jun-21 | Grant | 3,466 | -- | -- | 53% 6.6K to 10.07K | |
| 22-Mar-21 8:33 PM View: | Black Diamond Therapeutics,... (BDTX) | 18-Mar-21 | Grant | 547 | $24.01 | $13,133.50 | < 1% 3.45M to 3.45M | 5% |
| 18-Mar-21 5:11 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 07-Dec-20 5:09 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Private Purchase Duplicate | 4,398,600 | $0.62 | $2,735,930.00 | 214% 2.05M to 6.45M | |
| 22-Sep-20 5:42 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Conversion Duplicate | 2,291,300 | -- | -- | 100% 0 to 2.29M | |
| 22-Sep-20 5:42 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Purchase Duplicate | 769,230 | $13.00 | $9,999,990.00 | 34% 2.29M to 3.06M | |
| 14-Aug-20 4:30 PM View: | Crispr Therapeutics Ag (CRSP) | 13-Aug-20 | Acquisition (other) | 57 | -- | -- | 29% 0.2K to 0.26K | |
| 14-Aug-20 4:30 PM View: | Crispr Therapeutics Ag (CRSP) | 13-Aug-20 | Acquisition (other) | 14 | -- | -- | 5% 0.26K to 0.27K | |
| 28-Jul-20 5:22 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase Duplicate | 3,151,260 | $2.25 | $7,090,340.00 | 44% 7.23M to 10.38M |